Higher radiation dose may boost rectal cancer remission
NCT ID NCT07200141
First seen Nov 01, 2025 · Last updated May 12, 2026 · Updated 28 times
Summary
This phase 2 trial tests whether a higher radiation dose (58.75 Gy) given before surgery can improve complete response rates in 156 adults with locally advanced rectal cancer, compared to the standard dose (50 Gy). Participants receive radiation plus chemotherapy, then surgery or watchful waiting. The study aims to see if the stronger dose leads to better tumor shrinkage and long-term control.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED RECTAL ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.